Premium
Oculis Holding AG (OCS)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-25 | Dr. Arshad M. KhananiChair of Retina Scientific Advisory Board & Independent Director | 625,00 | 499,03k | Derivative Exercise and Retained Stock | 798,45 | 8,90k | 7,55% |
| 2025-03-13 | Ms. Christina M. AckermannIndependent Director | 1,86k | 56,58k | Achat | 30,45 | 5,12k | 56,92% |
| 2026-03-09 | Dr. Riad SherifCEO & Director | -25,00k | 867,65k | Vente | 33,06 - 36,24 | 1,29M | -1,91% |
| 2026-02-25 | Dr. Arshad M. KhananiChair of Retina Scientific Advisory Board & Independent Director | 625,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,28k | 8,17% |
| 2026-02-13 | Mr. Anthony A. RosenbergIndependent Chairman | -5,07k | 0,00 | Other Disposition | - | 118,99k | -4,09% |
| 2026-02-13 | Ms. Sylvia CheungCFO | -3,51k | 0,00 | Other Disposition | - | 73,81k | -4,53% |
| 2026-02-13 | Dr. Riad SherifCEO & Director | -46,07k | 0,00 | Other Disposition | - | 1,03M | -4,27% |
| 2026-02-13 | Mr. Páll Ragnar JóhannessonChief Business Officer | -13,07k | 0,00 | Other Disposition | - | 255,76k | -4,86% |
| 2026-01-05 | Dr. Riad SherifCEO & Director | 12,30k | 0,00 | Derivative Exercise and Retained Stock | - | 1,08M | 1,15% |
| 2025-12-04 | Mr. Anthony A. RosenbergIndependent Chairman | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 124,06k | 2,70% |
| 2025-12-04 | Ms. Christina M. AckermannIndependent Director | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 3,26k | - |
| 2025-12-04 | Mr. Robert K. WarnerIndependent Director | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 6,53k | 100,00% |
| 2025-12-04 | Dr. Arshad M. KhananiChair of Retina Scientific Advisory Board & Independent Director | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 7,65k | 74,42% |
| 2025-11-29 | Dr. Arshad M. KhananiChair of Retina Scientific Advisory Board & Independent Director | 1,89k | 0,00 | Derivative Exercise and Retained Stock | - | 4,39k | 75,44% |
| 2025-11-13 | Mr. Lionel CarnotIndependent Director | 15,00k | 289,18k | Achat | 19,28 | 32,50k | 85,71% |
| 2025-10-09 | Ms. Christina M. AckermannIndependent Director | -7,46k | 156,75k | Vente | 21,01 | 0,00 | -100,00% |
| 2025-10-05 | Dr. Riad SherifCEO & Director | 12,30k | 0,00 | Derivative Exercise and Retained Stock | - | 1,07M | 1,17% |
| 2025-09-23 | Dr. Riad SherifCEO & Director | -25,00 | 450,00 | Vente | 18,00 | 1,05M | -0,00% |
| 2025-09-04 | Mr. Anthony A. RosenbergIndependent Chairman | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 120,80k | 2,78% |
| 2025-09-04 | Ms. Christina M. AckermannIndependent Director | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 3,26k | - |
| 2025-09-04 | Mr. Robert K. WarnerIndependent Director | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 3,26k | - |
| 2025-09-04 | Dr. Arshad M. KhananiChair of Retina Scientific Advisory Board & Independent Director | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 10,81k | 43,27% |
| 2025-08-29 | Dr. Arshad M. KhananiChair of Retina Scientific Advisory Board & Independent Director | 1,89k | 0,00 | Derivative Exercise and Retained Stock | - | 7,54k | 33,33% |
| 2025-07-05 | Dr. Riad SherifCEO & Director | 12,30k | 0,00 | Derivative Exercise and Retained Stock | - | 1,05M | 1,18% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
